Skip to content

Fast Track Total Knee Arthroplasty: Local Infiltration Analgesia vs Femoral Nerve Block

Fast-track Rehabilitation Protocol for Total Knee Arthroplasty: A Randomized Controlled Trial Comparing Local Infiltration Analgesia With Femoral Nerve Block

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01966263
Enrollment
80
Registered
2013-10-21
Start date
2013-11-30
Completion date
2015-12-31
Last updated
2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Knee

Keywords

total knee arthroplasty, femoral nerve block, local infiltration analgesia, fast track

Brief summary

The objective of this study is to determine whether either a femoral nerve block (FNB) or local infiltration analgesia (LIA) is a better anesthetic technique to achieve optimal functional outcome after one year in patients receiving a total knee arthroplasty and following a fast track rehabilitation protocol.

Detailed description

For an optimal and fast recovery after total knee arthroplasty (TKA), a fast track rehabilitation protocol has been developed. The literature is not yet conclusive about the optimal anesthestic technique. The optimal technique should support fast mobilization by giving good pain relieve with minimal side effects such as nausea, drowsiness and muscle weakness. If pain relieve is optimal, the patient mobilizes fast and length of stay is shortened. But does fast recovery lead to better functional outcome? The objective of this study is to determine whether either a femoral nerve block (FNB) or local infiltration analgesia (LIA) is a better anesthetic technique to achieve optimal functional outcome after one year in patients receiving a total knee arthroplasty and following a fast track rehabilitation protocol.

Interventions

PROCEDURELIA of the posterior capsule of the knee

the surgeon infiltrates the posterior capsule of the knee using 100 mL ropivacaine 0.2% with 0.5 mg epinephrine.

PROCEDURELIA of the anterior capsule of the knee

the surgeon infiltrates the anterior capsule of the knee using 50 mL ropivacaine 0.2% with 0.25 mg epinephrine.

PROCEDURELIA of the subcutaneous tissue of the knee

the surgeon infiltrates the subcutaneous tissue of the knee using 50 mL ropivacaine 0.2% before wound closure.

PROCEDUREFNB with catheter

pre-operatively the anesthesiologist will ultrasound guided place a catheter close to the femoral nerve using sodium chloride (NaCl 0.9%) (no local anesthetic). During surgery, when the LIA of the posterior capsule is performed, 20 mL ropivacaine 0.2% will be administered through the catheter to create a femoral nerve block (FNB). Postoperatively patients will receive 20 mL ropivacaine 0.2% through the catheter 6 times daily for 24 hours

Sponsors

Sint Maartenskliniek
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) physical health status I-II * patient presents with non-inflammatory primary knee osteoarthritis (radiological confirmation) * patient is planned for a primary unilateral posterior-stabilized tri-compartmental cemented total knee replacement (Genesis II - PS) * patient is scheduled for fast track protocol * patient plans to be available fot follow-up through one year post-operative * written informed consent

Exclusion criteria

* any contra-indication for locoregional anesthesia * any contra-indication for spinal anesthesia * traumatic osteoarthritis requiring TKA * an active, local infection or systemic infection * known hypersensitivity to amide-type local anesthetics * known intolerance or contraindication for opioids, nonsteroidal antiinflammatory drugs (NSAIDs) or paracetamol * a Body Mass Index \> 40 kg/m2 * inability to walk independently (inability to walk at least 10 consecutive meters without a walking aid) * scheduled for contralateral TKA within one year postoperative * scheduled for another operation within 3 months postoperative * physical, emotional or neurological conditions that would compromize compliance with postoperative rehabilitation and follow-up * chronic opioid analgesic therapy * chronic gabapentin or pregabalin analgesic therapy * rheumatoid arthritis

Design outcomes

Primary

MeasureTime frameDescription
Stair Climbing Task (SCT)one yearThe SCT assesses the ability to ascend and descend a flight of stairs, as well as lower extremity strength, power, and balance.

Secondary

MeasureTime frameDescription
Timed Up and Go Test (TUG)1 yearThe TUG assesses basic mobility skill as well as strength, balance, and agility. Originally developed for frail elderly people as the Get-Up and Go Test in 1986, it was adapted in 1991 to include the time component. The TUG is used in a range of populations from children to the elderly and for many conditions, including osteoarthritis, joint arthroplasty, rheumatoid arthritis, hip fractures, stroke, vertigo, and cerebral palsy.
Six Minute Walking Test (6MWT)1 yearThe 6MWT assesses endurance and ability to walk over longer distances. The 6MWT was first described as a field test for physical fitness in 1963 and then as a 12-minute walk test in people with chronic bronchitis. The 6MWT was found to perform as well as the 12-minute walk, and is now used to assess the submaximal level of functional performance at a similar level required for daily physical activities. Used in many conditions, such as osteoarthritis, cardiopulmonary disease, stroke, traumatic brain injury, patients who have undergone an amputation, Parkinson's disease, and Alzheimer's disease, as well as in elderly populations and children.

Countries

Netherlands

Participant flow

Participants by arm

ArmCount
Local Infiltration Analgesia (LIA)
local infiltration analgesia is an anesthetic technique that consists of the infiltration of operated tissue with a long acting local anesthetic during surgery to achieve postoperative pain relieve. In this study LIA of the knee will exist of: 1. local infiltration analgesia (LIA) of the posterior capsule of the knee, 2. LIA of the anterior capsule of the knee and 3. LIA of the subcutaneous tissue of the knee LIA of the posterior capsule of the knee: the surgeon infiltrates the posterior capsule of the knee using 100 mL ropivacaine 0.2% with 0.5 mg epinephrine. LIA of the anterior capsule of the knee: the surgeon infiltrates the anterior capsule of the knee using 50 mL ropivacaine 0.2% with 0.25 mg epinephrine. LIA of the subcutaneous tissue of the knee: the surgeon infiltrates the subcutaneous tissue of the knee using 50 mL ropivacaine 0.2% before wound closure.
40
Femoral Nerve Block (FNB)
a femoral nerve block is an anaesthetic technique that consists of anesthetizing the femoral nerve proximal of the operating area to achieve numbness distal of the block puncture site. A catheter can be placed, so the nerve can be anesthetized continuously or repeatedly for post-operative pain relieve. In this study the FNB with catheter will be combined with local infiltration analgesia (LIA) of the posterior capsule of the knee LIA of the posterior capsule of the knee: the surgeon infiltrates the posterior capsule of the knee using 100 mL ropivacaine 0.2% with 0.5 mg epinephrine. FNB with catheter: pre-operatively the anesthesiologist will ultrasound guided place a catheter close to the femoral nerve using sodium chloride (NaCl 0.9%) (no local anesthetic). During surgery, when the LIA of the posterior capsule is performed, 20 mL ropivacaine 0.2% will be administered through the catheter to create a femoral nerve block (FNB). Postoperatively patients will receive 20 mL ropivacaine 0.2% through the catheter 6 times daily for 24 hours
40
Total80

Baseline characteristics

CharacteristicLocal Infiltration Analgesia (LIA)Femoral Nerve Block (FNB)Total
Age, Continuous64 years
STANDARD_DEVIATION 6.9
66 years
STANDARD_DEVIATION 6.3
65 years
STANDARD_DEVIATION 6.6
ASA physical status
ASA 1
13 Participants8 Participants21 Participants
ASA physical status
ASA 2
15 Participants24 Participants39 Participants
ASA physical status
ASA 3
12 Participants8 Participants20 Participants
BMI28.4 kg/m^2
STANDARD_DEVIATION 4.2
30.0 kg/m^2
STANDARD_DEVIATION 4.9
29.2 kg/m^2
STANDARD_DEVIATION 4.6
Region of Enrollment
Netherlands
40 participants40 participants80 participants
Sex: Female, Male
Female
20 Participants23 Participants43 Participants
Sex: Female, Male
Male
20 Participants17 Participants37 Participants
Side of surgery
left
17 Participants22 Participants39 Participants
Side of surgery
right
23 Participants18 Participants41 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 400 / 40
serious
Total, serious adverse events
0 / 400 / 40

Outcome results

Primary

Stair Climbing Task (SCT)

The SCT assesses the ability to ascend and descend a flight of stairs, as well as lower extremity strength, power, and balance.

Time frame: one year

Population: One patient from group FNB was excluded due to revision surgery of the knee; one patient from group FNB withdrew from follow up due to the development of a malignancy. One patient in group FNB and three patients in group LIA were excluded due to TKA of the contralateral knee. In group LIA one patient withdrew from follow up due to the development of a severe eye disorder requiring intensive treatment. One patient from group FNB was unable to perform the 6MWT due to severe backache.

ArmMeasureValue (MEAN)Dispersion
Local Infiltration Analgesia (LIA)Stair Climbing Task (SCT)14.3 secondsStandard Deviation 7.1
Femoral Nerve Block (FNB)Stair Climbing Task (SCT)13.8 secondsStandard Deviation 4.7
Secondary

Six Minute Walking Test (6MWT)

The 6MWT assesses endurance and ability to walk over longer distances. The 6MWT was first described as a field test for physical fitness in 1963 and then as a 12-minute walk test in people with chronic bronchitis. The 6MWT was found to perform as well as the 12-minute walk, and is now used to assess the submaximal level of functional performance at a similar level required for daily physical activities. Used in many conditions, such as osteoarthritis, cardiopulmonary disease, stroke, traumatic brain injury, patients who have undergone an amputation, Parkinson's disease, and Alzheimer's disease, as well as in elderly populations and children.

Time frame: 1 year

Population: One patient from group FNB was excluded due to revision surgery of the knee; one patient from group FNB withdrew from follow up due to the development of a malignancy. One patient in group FNB and three patients in group LIA were excluded due to TKA of the contralateral knee. In group LIA one patient withdrew from follow up due to the development of a severe eye disorder requiring intensive treatment. One patient from group FNB was unable to perform the 6MWT due to severe backache.

ArmMeasureValue (MEAN)Dispersion
Local Infiltration Analgesia (LIA)Six Minute Walking Test (6MWT)489 metersStandard Deviation 71
Femoral Nerve Block (FNB)Six Minute Walking Test (6MWT)505 metersStandard Deviation 84
Secondary

Timed Up and Go Test (TUG)

The TUG assesses basic mobility skill as well as strength, balance, and agility. Originally developed for frail elderly people as the Get-Up and Go Test in 1986, it was adapted in 1991 to include the time component. The TUG is used in a range of populations from children to the elderly and for many conditions, including osteoarthritis, joint arthroplasty, rheumatoid arthritis, hip fractures, stroke, vertigo, and cerebral palsy.

Time frame: 1 year

Population: One patient from group FNB was excluded due to revision surgery of the knee; one patient from group FNB withdrew from follow up due to the development of a malignancy. One patient in group FNB and three patients in group LIA were excluded due to TKA of the contralateral knee. In group LIA one patient withdrew from follow up due to the development of a severe eye disorder requiring intensive treatment. One patient from group FNB was unable to perform the 6MWT due to severe backache.

ArmMeasureValue (MEAN)Dispersion
Local Infiltration Analgesia (LIA)Timed Up and Go Test (TUG)7.8 secondsStandard Deviation 1.9
Femoral Nerve Block (FNB)Timed Up and Go Test (TUG)7.6 secondsStandard Deviation 1.2

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026